Banca Mediolanum S.p.A. (BMED.MI)
EUR 11.55
(-0.26%)
EUR 11.55
(-0.26%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.72 Billion | 2.29 Billion | 909.3 Million | -6.99 Million | 363.26 Million | 356.62 Million |
| Net Income | 821.85 Million | 521.8 Million | 713.05 Million | 434.46 Million | 565.43 Million | 255.71 Million |
| Depreciation & Amortization | 66.64 Million | 67.19 Million | 48.9 Million | 46.11 Million | 45.2 Million | 37.16 Million |
| Deferred income taxes | - | - | - | -48.99 Million | -46.4 Million | - |
| Stock-based compensation | - | - | - | 2.87 Million | 1.19 Million | - |
| Change in working capital | -3.02 Billion | 1.48 Billion | 1.08 Billion | -134.19 Million | 1.52 Billion | -810.05 Million |
| Other non-cash items | 540.72 Million | 222.21 Million | -936.17 Million | -307.26 Million | -1.73 Billion | 910.97 Million |
| Investing Cash Flow | -52.26 Million | -34.06 Million | -38.14 Million | -38.16 Million | -16.37 Million | -30.08 Million |
| Investments in PPE | -52.26 Million | -59.48 Million | -60.8 Million | -42.76 Million | -35.21 Million | -44.66 Million |
| Acquisitions | - | - | 5.45 Billion | 1.72 Billion | 35 Thousand | 906 Thousand |
| Investment purchases | - | - | -5.99 Billion | -2.17 Billion | - | -11.34 Million |
| Sales/Maturities of investments | - | 427.16 Million | 535.12 Million | 443.94 Million | - | - |
| Other Investing Activities | -10.65 Million | -401.74 Million | 22.66 Million | 4.6 Million | 18.8 Million | 14.58 Million |
| Financing Cash Flow | -385.64 Million | -428.66 Million | -737.96 Million | 4.92 Million | -294.26 Million | -303.2 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | -400.86 Million | -438.01 Million | -743.7 Million | - | -300.69 Million | -293.45 Million |
| Common Stock Repurchased | - | - | - | - | - | -9.92 Million |
| Common Stock Issuance | 15.21 Million | 6.51 Million | 5.73 Million | 4.92 Million | 6.42 Million | 168 Thousand |
| Other Financing Activities | 15.21 Million | 6.51 Million | -244.61 Million | 4.92 Million | -147.62 Million | -9.75 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -3.02 Billion | 1.48 Billion | 1.08 Billion | -134.19 Million | 1.52 Billion | -8.8 Billion |
| Cash at beginning of period | 2.35 Billion | 519.02 Million | 385.83 Million | 169.95 Million | 117.33 Million | 93.99 Million |
| Cash at end of period | 188.13 Million | 2.35 Billion | 519.02 Million | 129.72 Million | 169.95 Million | 117.33 Million |
| Capital Expenditure | -52.26 Million | -59.48 Million | -60.8 Million | -42.76 Million | -35.21 Million | -44.66 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -2.16 Billion | 1.83 Billion | 133.18 Million | -40.23 Million | 52.62 Million | 23.34 Million |
| Free Cash Flow | -1.77 Billion | 2.23 Billion | 848.49 Million | -49.76 Million | 328.04 Million | 311.96 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 229.4 Million | 220.51 Million | 249.7 Million | 821.85 Million | 208.84 Million | 185.05 Million |
| Depreciation & Amortization | - | - | 7.57 Million | 66.64 Million | 12.51 Million | 12.63 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | -3.02 Billion | - | - |
| Other non-cash items | -229.4 Million | -220.51 Million | -249.7 Million | 540.72 Million | -208.84 Million | -185.05 Million |
| Investing Cash Flow | - | - | - | -52.26 Million | - | - |
| Investments in PPE | - | - | - | -52.26 Million | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | -10.65 Million | - | - |
| Financing Cash Flow | - | - | - | -385.64 Million | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | -400.86 Million | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 15.21 Million | - | - |
| Other Financing Activities | - | - | - | 15.21 Million | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | -3.02 Billion | - | - |
| Cash at beginning of period | - | - | 557.93 Million | 2.35 Billion | 316.4 Million | 615.87 Million |
| Cash at end of period | - | - | 188.13 Million | 188.13 Million | 557.93 Million | 316.4 Million |
| Capital Expenditure | - | - | - | -52.26 Million | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | -369.79 Million | -2.16 Billion | 241.52 Million | -299.46 Million |
| Free Cash Flow | - | - | 15.15 Million | -1.77 Billion | 25.02 Million | 25.26 Million |
NGEX
300232
PCHM
DGR
300252
NMHI